Applied Biological Materials (abm)

Normal Primary Diploid Mortal NIH Swiss Mouse Embryonic Cells

Product Code:
 
ABM-T4138
Product Group:
 
Primary Cells
Cell System:
 
Stem Cell System
Cell Type:
 
Fibroblasts
Species:
 
Mouse
Regulatory Status:
 
RUO
 

No additional charges, what you see is what you pay! *

CodeSizePrice
ABM-T41385x10? cells / 1.0 mlEnquire
Please contact us for pricing.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Canada.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Description:
These primary normal fibroblast like NIH Swiss mouse cells (Cat. T4138) help define the starting normal genetic background of the NIH Swiss mouse diploid cell type. These cells were prepared from fine minces of whole 17 to 19 days old NIH Swiss mouse embryos by the methods of Todaro and Green (ref 2) and grow well in the growth media used to grow all the R/J Model cells.This cell line is part of an eight cell R/J Model of Metastatic Progression designed using the NIH Swiss mice species to acquire isogenic cell types (T4138, T8981,T3317, T8144-T8148) that capture genetic/phenotypic stages in the progression to highly metastatic growth within this same species. Compared to some other models, the metastasis related changes captured in this unique progression model are easier to discern above their less noisy isogenic background and have progressed within their native NIH Swiss in vivo micro-environments. This isogenic R/J Metastasis Cell Model was produced by an in vitro/in vitro six-step progression from mortal normal NIH Swiss mouse cells (Cat. T4138) that were used to produce immortal pre-cancer NIH/3T3 cells (Cat. T8981) that were transfected with the human HRAS oncogene to produce transformed cancer GhrasT-NIH/3T3 cells (Cat. T3317). Then beginning with a series of in vivo/in vitro progressive transfers of GhrasT-NIH/3T3 cells produced primary tumor T1-A cells (Cat. T8144) that produced local metastatic lesion T2-A cells (Cat. T8145) that simultaneously produced twin distant metastatic lung lesion T3-PA cells (Cat. T8146) with its twin distant metastatic liver lesion cells (Cat. T1847). The liver derived cells produced highly distant metastatic lung lesion cells (Cat T1848) which retained the human HRAS oncogene and they demonstrated a highly metastatic phenotype as they produced wide-spread simultaneous external and internal metastases in multiple sites in multiple mice when injected i.v. into nude NIH Swiss mice.Complete list of cells included in the R/J Metastasis Model:Cat. T8981 - NIH-3T3 CellsCat. T4138 - Normal Primary Diploid Mortal NIH Swiss Mouse Embryonic CellsCat. T3317 - HRAS Stably Expressing Transformed NIH/3T3 Cell Line (GhrasT-NIH/3T3)Cat. T8144 - Primary Tumor Cell Line (T1-A )Cat. T8145 - Local Metastasis Tumor Cell Line (T2-A)Cat. T8146 - Distant Pulmonary Metastasis Tumor Cell Line (T3-PA)Cat. T8147 - Distant Hepatic Metastasis Tumor Cell Line (T3-HA)Cat. T8148 - Highly Metastatic Distant Pulmonary Tumor Cell Line (T4-PA)
Growth Conditions:
PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. PriGrow III (TM003) + 10% FBS + 1% Penicillin/Streptomycin Solution (G255), 37.0°C, 5% CO2.Note: avoid excessive alkalinity in media; renew media twice weekly.
Growth Properties:
Adherent, fibroblast-like
Tissue:
Embryo

References

Lu, J. (2019). The Warburg metabolism fuels tumor metastasis. Cancer and Metastasis Reviews, 38, 157-164.Stringari, C., Nourse, J. L., Flanagan, L. A., & Gratton, E. (2012). Phasor fluorescence lifetime microscopy of free and protein-bound NADH reveals neural stem cell differentiation potential. PloS one, 7(11), e48014.Ray, D.B.,  Merrill, G.A.,  Brenner, F.J., Lytle, L.S., Lam, T., McElhinney, A.,  Anders, J., Tauber, T.R., Lyker, J.K., Barcus, S., Leslie, K.H., Kramer, J.M., Rubenstein, E.M., Schanz, K.P., Parkhurst, A.J., Peck, M., Good, K., Granath, K.L., Cifra, N., Wantz Detweiler, J., Stevens, L., Albertson, R.A., Deir, R., Stewart, E., Wingard, K., Ricardson, M. R., Blizare, S. B., Gillespie, L. F., Kriley, C.F., Rzewnicki, D., and Jones, D.H., ?T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.?  Experimental Cell Research, 340(1): (2016). 1-11. Open access: https://doi.org/10.1016/j.yexcr.2015.07.029Towne, Camden M., Dudt, Jan F., and Ray, Durwood B., ?Effect of Mansoa alliacea (Bignonaceae) leaf extract on embryonic and tumorigenic mouse cell lines.? Journal of Medicinal Plants Research Vol. 9(29). pp.799-805, August 3, 2015.Scahill, S. D., Sherman, K. J., Guidry, J. J., Walkowski, W., Nguyen, T., Ray, D. B., ... & Paul, D. (2023). In vitro characterization of a novel murine model of cancerous progression. Advances in Cancer Biology-Metastasis, 7, 100101.